Status:
UNKNOWN
Development of a Patient-reported Outcome Instrument for Patients With Lumbar Degenerative Disease After Lumbar Fusion
Lead Sponsor:
Peking University Third Hospital
Conditions:
Lumbar Spine Degeneration
Eligibility:
All Genders
Brief Summary
The commonly used scales (ODI+JOA-29+VAS) lack the assessment of lumbar stiffness, and there is no scale for evaluating lumbar stiffness in China.Based on the Delphi method and the analytic hierarchy ...
Detailed Description
Although lumbar fusion can improve function by correcting deformity,restoring spinal stability,and reducing pain, it also by intention leads to spinal stiffness which can impair function of daily acti...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Lumbar Spine Degeneration
- Plan for or have undergone lumbar fusion
- Be willing to participate in this research
Exclusion
- Combined with neurological disease such as Motor neuron disease, Progressive muscular dystrophy, Peripheral neuropathy, Spinal cord disease, et al.
- Combined with severe cervical/thoracic spine disease or other diseases that seriously affect the quality of life
- Suffer lumbar spine trauma after lumbar fusion
- Preoperative cases exclude patients who plan for revision surgery
- Be unwilling to participate in this research
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04781517
Start Date
May 1 2020
End Date
May 1 2023
Last Update
February 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191